FDA gets mandatory power to track tobacco through supply chains
H.R. 6844 — Tobacco TRACE Act · Filed by Herbert Conaway (D-NJ) · 5 cosponsors · Introduced Dec 18, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the FDA to mandate tracking codes on tobacco product labels by June 1, 2026, to monitor how tobacco moves through the distribution system. Currently the FDA may optionally require such codes; this bill makes it mandatory, giving regulators a tool to detect counterfeit products, prevent tax evasion, and enforce compliance with tobacco laws.
Why we flagged it
The bill's sole operative mechanism is converting FDA's discretionary authority to mandate tobacco tracking codes into a binding obligation. This is a straightforward regulatory-enforcement measure, not a tax, subsidy, or commemorative provision.
What the text implies
- Tracking codes may enable state and local tax authorities to cross-reference illicit tobacco sales, potentially increasing tax compliance and revenue recovery.
- Mandatory codes could increase compliance costs for smaller tobacco manufacturers and distributors, potentially consolidating market share toward larger players with existing supply-chain infrastructure.
- International tobacco suppliers may face barriers to U.S. market entry if they lack compatible tracking systems, affecting import competition.
- The June 1, 2026 deadline is tight; implementation delays could trigger enforcement actions against non-compliant manufacturers before systems are operational.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Mandatory tracking codes strengthen FDA enforcement against counterfeit and illicit tobacco, reduce tax evasion, and improve supply-chain transparency — all public-health and consumer-protection gains. The compliance burden falls on tobacco manufacturers and distributors, not consumers.
Who stands to gain
- tobacco manufacturers (compliance cost offset by reduced counterfeiting losses)
- supply-chain software vendors (tracking-system implementation)
- state tax authorities (improved illicit-tobacco detection)
Named in the bill
FDA, Federal Food, Drug, and Cosmetic Act, tobacco manufacturers, tobacco distributors, state tax authorities
Where it stands
5 cosponsors: 5 Democrats.
- Dec 18, 2025 — Introduced · Congress.gov: “Introduced in House”
- Dec 18, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
4 lobbying clients named this bill on 8 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $4,424,000 in lobbying spend. A filing names 13 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 72% of bills with at least one filing.
Herbert Conaway, the sponsor, reported $527,013 in PAC receipts in the 2026 cycle.
- Altria Client Services LLC — $3,290,000 on 1 filing
- Tobacco-free Kids Action Fund — $874,000 on 3 filings
- American Lung Association — $190,000 on 2 filings
- Campaign for Tobacco-free Kids — $70,000 on 2 filings
Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (376 characters) on May 21, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 21, 2026 · page rendered 2026-10-20.
“FDA gets mandatory power to track tobacco through supply chains” QuorumCivic. https://share.quorumcivic.app/bill/119/hr6844 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.